Contineum Therapeutics (CTNM) Profit After Tax (2023 - 2024)
Historic Profit After Tax for Contineum Therapeutics (CTNM) over the last 2 years, with Q4 2024 value amounting to -$14.6 million.
- Contineum Therapeutics' Profit After Tax fell 8792.64% to -$14.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$42.3 million, marking a year-over-year decrease of 28629.4%. This contributed to the annual value of -$42.3 million for FY2024, which is 28617.96% down from last year.
- Per Contineum Therapeutics' latest filing, its Profit After Tax stood at -$14.6 million for Q4 2024, which was down 8792.64% from -$10.3 million recorded in Q3 2024.
- In the past 5 years, Contineum Therapeutics' Profit After Tax ranged from a high of $41.6 million in Q2 2023 and a low of -$14.6 million during Q4 2024